bild
DEUTSCHLAND BIOTECHNOLOGIE BIONTECH
File- This Dec. 4, 2017, photo shows the Pfizer company logo at the company's headquarters in New York. The federal government has agreed to pay nearly $2 billion for 100 million doses of a potential COVID-19 vaccine being developed by the U.S. drugmaker and its German partner BioNTech. (AP Photo/Richard Drew, File)
Instruktionen
MONDAY, DEC. 4, 2017, PHOTO
Lizenz
Rights Managed
Erstellungsdatum
20171204
Ort
NEW YORK DEUTSCHLAND
Credit
KEYSTONE
Source
AP
Byline
RICHARD DREW
Grösse
5760 x 3840 px
Dateityp
JPEG